NVCT

NUVECTIS PHARMA INC

NVCT·67080T108·US·Common Stock·Healthcare - Biotechnology-13D/G

NVCT (NUVECTIS PHARMA INC) is held by 51 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($18.4M), VANGUARD CAPITAL MANAGEMENT LLC ($16M), GEODE CAPITAL MANAGEMENT, LLC ($8M). Net institutional sentiment: Bullish.

51
Holders
(3 Elite)
$76.2M
Total Value
82% (51)
Consensus
42 buying - 9 selling
13F: Insider & Congress: Updated regularly
NVCT

Smart Money Verdict

View all
Loading verdict
Held by 51 funds
3 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jun 12, 2026 · Activists Aug 6, 2026 · Congress none

ActivistSOSoleus Capital Management, L.P.5.1%Aug 6, 2026
InsiderSJSanchez JuanVest 35K shJun 11, 2026
InsiderHKHoberman KennethVest 35K shJun 11, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1M(+31.0%)$18.4M0.0%+152.49%
36
Increased
872,482(+32.2%)$16M0.0%+125.86%
36
Increased
432,273(+12.5%)$8M0.0%+158.06%
31
New
275,000$5.1M0.0%+35.94%
37
Increased
248,198(+49.0%)$4.6M0.0%+126.06%
37
Increased
217,286(+106.4%)$4M0.0%+94.67%
43
Increased
146,714(+18.1%)$2.7M0.0%+147.07%
31
Increased
127,554(+11.1%)$2.3M0.0%+158.41%
29
Increased
118,297(+28.4%)$2.2M0.0%+130.43%
32
Increased
115,532(+47.3%)$2.1M0.0%+111.52%
36
Increased
69,200(+79.5%)$1.3M0.0%+94.20%
39
Increased
57,133(+15.1%)$1.1M0.0%+175.73%
29
Increased
67,155(+161.7%)$917,6610.0%+70.17%
40
Increased
40,823(+143.7%)$750,7350.0%+79.31%
40
Increased
36,770(+21.3%)$676,1920.0%+165.91%
29
New
31,886$586,3850.0%+35.94%
34
Increased
31,394(+1109.3%)$577,3350.0%+42.13%
39
New
27,963$514,2400.0%+35.94%
33
New
27,200$500,2080.0%+35.94%
33
Decreased
20,480(-50.2%)$376,6270.0%+261.70%
0

Showing 1-20 of 54

1 / 3
NVCTNVCTNUVECTIS PHARMA INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used